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allografts demonstrate superior hemodynamics, free-
dom from thrombosis, and reduced risk of infection.
Their durability has been questioned, however, and this
is a limitation to their use.1,2 It is not known what fac-
tors determine valve graft longevity. Age of the recipi-
ent,2-5 graft size,6 immunologic differences,4 preserva-
tion methods,3 and operative technique7 are some of the
factors suggested as influences on the pathologic fate of
the valve. Moreover, differences may exist in the dura-
bility of aortic, as opposed to pulmonary, valve
grafts.3-5 Because of the scarcity of these tissues, both
aortic and pulmonary valves must be available if the
maximum number of patients is to benefit from their
use. Clinical studies that compare the durability of aor-
tic and pulmonary allograft valves are hampered by the
numerous confounding variables that make such analy-
A ortic and pulmonary valve allografts have beenwidely used for patients with congenital heart
defects. Allografts are preferable to the main alterna-
tives, mechanical valves and bioprostheses, because
Objective: Allograft valves are frequently used in the repair of congenital
cardiac anomalies. The failure rate may differ depending on the type of allo-
graft used. Previous studies have shown that rat aortic valve grafts exhibit
synthesis of procollagen, suggesting a capacity for repair and regeneration
after implantation. No studies of pulmonary valve grafts in the heterotopic
rat implant model have thus far been reported. This study was designed to
investigate whether pulmonary valve grafts maintain in vivo viability, as
demonstrated by procollagen synthesis, and whether cryopreservation, histo-
compatibility, or both affect this property.
Methods: Cryopreserved and fresh rat pulmonary valves were implanted into
the abdominal aorta of syngeneic and allogeneic recipients. The grafts and
native valves were excised 3 to 21 days after implantation. Valves were sec-
tioned and immunohistochemically stained for procollagen. Computerized
morphometry was used to calculate changes in intima, media, and adventitia
as a percentage of cross-sectional area of the graft. Procollagen content was
graded by semiquantitative methods.
Results: Pulmonary valve grafts had significantly greater collagen density in
the intima and adventitia compared with native aortic and pulmonary tissues,
but collagen density in the media was similar in all groups. The grafts
demonstrated appreciably greater procollagen than the corresponding native
valves. These findings were consistent in all grafts (ie, both fresh and cryo-
preserved, both syngeneic and allogeneic), irrespective of duration of
implantation.
Conclusions: Procollagen synthesis occurs in pulmonary valve grafts early
after implantation, indicating viability of these tissues. This model of pul-
monary valve implantation may have wide applicability to questions of allo-
graft biology. (J Thorac Cardiovasc Surg 2000;120:596-603)
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sis complex. Therefore, experimental studies of allo-
graft valves may help to delineate differences in aortic
and pulmonary valves in a more well-controlled design.
The heterotopic aortic valve implant model has provid-
ed a useful approach to questions of valve graft biolo-
gy. This model has not previously been described with
pulmonary allografts, however, in part because of the
difficulty of performing the operative preparation with
the very delicate pulmonary valve.
This investigation was undertaken to establish the
technique of pulmonary valve allograft implantation in
the rat model. The model was then used to determine
whether synthesis of procollagen, an important struc-
tural protein, can be demonstrated in the grafted pul-
monary valve. Finally, the effects of cryopreservation
and immunologic differences between donor and recip-
ient were studied to understand whether these variables
affect procollagen production.
Methods
Experimental preparation. Heterotopic transplantation of
pulmonary valve grafts was performed on the basis of the
technique of aortic valve graft implantation described origi-
nally by Yankah and colleagues.8 Male Lewis rats weighing
100 to 125 g underwent general anesthesia with intraperi-
toneal sodium pentobarbital (65 mg/kg body weight). Under
sterile conditions, the heart and pulmonary arteries were
excised and rinsed in 0.9% saline solution containing heparin
(100 U/mL). The pulmonary valve was excised with a 1-mm
cuff of ventricular muscle, and a 5-mm portion of distal artery
was attached to permit construction of the anastomoses.
Some valves were transplanted immediately, whereas others
were transported overnight in vials of heparinized saline solu-
tion on ice to CryoLife, Inc (Marietta, Ga) for routine cryo-
preservation processing. The grafts underwent antibiotic ster-
ilization, immersion in a graded series of dimethyl sulfoxide
concentrations to minimize ice crystal formation during cry-
opreservation, controlled rate freezing at a rate of –1°C/min,
and storage in the vapor phase of liquid nitrogen between
–135°C and –196°C. The valves were returned by overnight
air on dry ice and on receipt were stored in the vapor phase of
liquid nitrogen until ready for use.
At the time of implantation, cryopreserved valves were
thawed by immersion in 37°C saline solution and rinsed
thoroughly before use. Fresh valves were left in
heparinized saline solution while the recipient animal was
prepared. Transplant recipients were 200- to 250-g rats of
the Lewis (syngeneic) or Brown Norway (strongly allo-
geneic, RT1 and non-RT1 incompatible) strains. The dis-
crepancy in the size of the donor and the recipient was
intended to achieve a more equal diameter of the graft and
the donor aorta, each of which was approximately 2 mm.
Animals were anesthetized with a single intraperitoneal
dose of pentobarbital (65 mg/kg body weight). Each recip-
ient underwent sterile laparotomy and dissection of the
abdominal aorta under a Nikon SMZ-10 stereoscopic zoom
microscope (Garden City, NY) with a usual magnification
of 14×. The recipient aorta was occluded proximally and
distally with vascular clamps and divided. An end-to-end
anastomosis of the distal end of the valve graft to the distal
end of the native aorta was performed with interrupted 10-
0 Ethilon nylon sutures (Ethicon, Inc, Somerville, NJ). A
second end-to-end anastomosis between the proximal end
of the graft and the proximal end of the native aorta was
constructed with a running 8-0 Prolene polypropylene
suture (Ethicon). None of the leaflets were included in the
suture line. Instead, a concerted effort was made to allow
the possibility that each leaflet remained mobile so that
valve coaptation could occur. The presence or absence of
leaflet mobility and coaptation is conjectural, however. The
distal clamp was then released to check for low pressure
flow and leakage followed by the release of the proximal
clamp. Patency was assessed, the abdomen was closed, and
the animals were allowed to recover.
Rats were allowed to survive for 3, 7, 14, or 21 days. Thus,
a total of 80 animals were studied, 20 for each of 4 durations
of implantation, with 5 each receiving fresh isografts, fresh
allografts, cryopreserved isografts, and cryopreserved allo-
grafts. Animals were anesthetized at preassigned time inter-
vals with pentobarbital (80 mg/kg) and exsanguinated by sev-
ering the jugular veins. The animals were then slowly
perfused through a femoral arterial line at 100 mm Hg with
20 mL of heparinzed saline solution (100 U/mL) and then
with 10 mL of methyl-Carnoy solution (60% methanol with
30% glacial acetic acid and 10% chloroform) over a 10-
minute period. The native aortic and pulmonary roots and the
grafted pulmonary valve were explanted. Specimens were
stored for an additional 24 hours in methyl-Carnoy solution
before being prepared for immunohistochemistry and routine
histology.
All animals received humane care in compliance with the
“Guide for the Care and Use of Laboratory Animals” pub-
lished by the National Institutes of Health (National Institutes
of Health publication No. 85-23, revised 1985).
Tissue preparation and histologic examination. All
specimens were prepared by dehydration in graded alco-
hols and xylenes and then infiltrated and embedded in
paraffin. Serial sections were cut 5-µm thick, positioned on
positively charged slides, and baked at 60°C for 60 min-
utes. Slides were deparaffinized and rehydrated through
xylene and graded alcohols to distilled water. Slides were
stained with hematoxylin and eosin (for general histology
and structure), aniline blue (for collagen), and Weigert’s
hematoxylin (for elastin). Weigert’s hematoxylin was used
to delineate the internal and external elastic laminae, which
were used for the demarcations between the intima, media,
and adventitia.
The areas and composition of the 3 separate regions were
quantified by using a computerized morphometric program
(Optimas 5.1, Bothell, Wash). Slides imaged on an Olympus
light microscope (Lake Success, NY) were carried by a video
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Table II. Relative amount of pulmonary graft comprising media
Mean SD P value
All grafts 28% 17%
By duration of implant
3 d 34% 14% .2
7 d 22% 12%
14 d 32% 21%
21 d 25% 18%
By histocompatibility
Syngeneic 23% 17% .3
Allogeneic 34% 15%
By graft treatment
Fresh 26% 19% .3
Cryopreserved 30% 15%
By combination treatment/compatibility
Fresh syngeneic 22% 20% .03
Fresh allogeneic 30% 17%
Cryopreserved syngeneic 24% 15%
Cryopreserved allogeneic 37%* 13%
*P = .008 versus fresh, syngeneic.
camera, processed from analog to digital by an Oculus model
TCX on board frame grabber (Coreco, Inc, St Laurent,
Quebec, Canada), and displayed on a video monitor. Intimal,
medial, and advential areas were measured by use of a thresh-
old-based pixel-counting algorithm. Total areas of the graft
and relative amounts of collagen staining in the intima,
media, and adventitia as a percentage of each layer were cal-
culated. Comparisons of graft to native aortic and pulmonary
specimens were made after data were reduced by means of
StatView statistical software (Abacus Concepts, Inc,
Berkeley, Calif). Among the grafts, the percentage of each
cross-sectional area that was the media was also calculated
and recorded.
Comparisons were made between groups by analysis of
variance with application of the Bonferroni inequality with
paired and unpaired t tests as appropriate.
Immunohistochemistry. Slides were deparaffinized in
xylene, rehydrated in graded alcohols, pretreated by immer-
sion in 0.1 mol/L sodium citrate (pH 8.6), and microwaved at
high power for 10 minutes. The slides were cooled for 20
minutes at room temperature, washed with 0.1 mol/L phos-
phate-buffered saline solution (PBS), treated with 3% H2O2
for 5 minutes to bind endogenous peroxidase, and washed
with PBS.
The slides were then incubated in procollagen protein
primary antibody (SPI-D8, University of Iowa) diluted 1:20
with 1% bovine serum albumin in 0.1 mol/L PBS (pH 7.5)
for 1 hour at room temperature. Slides were washed in PBS
and then incubated in horse anti-mouse secondary antibody
(Vector Labs, Burlingame, Calif) diluted 1:250 for 30 min-
utes at room temperature. Slides were washed in PBS and
then incubated in avidin-biotin complex (ABC Elite, Vector
Table I. Relative contribution of collagen to each layer of arterial walls
Native aorta Native pulmonary artery Pulmonary graft
Intima
Mean ± SD 0.3% ± 1.1% 0.1% ± 0.3% 2.0% ± 6.4%*
Median 0.0 0.0 0.02
25% trimmed mean 0.0 0.0 0.1
Media
Mean ± SD 3.6% ± 10.9% 5.9% ± 12.1% 4.9% ± 12.5%
Median 0.5 1.2 0.5
25% trimmed mean 0.6 1.4 0.6
Adventitia
Mean ± SD 19.5% ± 16.9% 18.0% ± 18.5% 12.9% ± 17.2%†
Median 14.0 9.4 6.3
25% trimmed mean 15.5 12.1 7.1
*P = .02 versus native pulmonary artery.
†P = .04 versus native pulmonary artery.
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Labs) for 30 minutes at room temperature. Slides were
washed in PBS and incubated in 175 mL of 0.1 mol/L
Trisma-HCl–buffered saline solution (pH 7.6) in 0.1 mol/L
PBS containing 0.6 mL of 3% H2O2 and 4 mg of
diaminobenzedine (Sigma Chemical Co, St Louis, Mo) for
7 minutes at 37°C. Slides were washed in distilled water,
counterstained for 10 seconds in 1% methyl green (Sigma)
at pH 5.4, dehydrated in 95% and 100% alcohols, and
placed under coverslips.
Hypertrophic human scar tissue was used as a positive
immunohistochemical control tissue for procollagen, and
staining with either the primary or secondary antibodies
deleted was the negative control. Native, nonoperated, pul-
monary and aortic valved conduits and native aortic and
native pulmonary valved conduits from transplanted animals
served as standard controls.
Experimental, standard, and control slides were examined
by light microscopy at 250×. Two observers blinded as to
specimen source and working independently graded slides by
using a 0 to 3+ scale (0, no staining; 1+, slight staining; 2+,
moderate staining; and 3+, staining throughout the majority
of media).
Results
Operative outcomes. To obtain the 80 animals used
in this study, a total of 120 animals underwent the oper-
ative procedure. There were 40 deaths before the time
scheduled for euthanasia. Each dead animal was sub-
jected to necropsy. The cause of death was considered
to be viral infection in all cases. Pulmonary valve grafts
increased to at least double their initial diameter, from
2 mm at the time of implantation to 4 mm at the time of
explantation. Rupture did not occur, however. In all
cases the distal native aorta was pulsatile, suggesting
the absence of any important obstruction within the
graft or at the anastomotic sites. None of the pulmonary
valve grafts were found to have become occluded with
thrombus at the time of excision.
Morphology and quantitative histology. Pul-
monary arterial walls, both native and graft, were
noticeably thinner than aortic specimens. The pul-
monary grafts demonstrated substantial dilatation and
appreciable intimal thickening, particularly with longer
durations of implantation.
The percentage of each layer of the specimen wall
composed of collagen is shown in Table I. There were
no significant differences in the collagen density of the
native aorta and pulmonary arteries. The arterial wall of
the pulmonary graft, however, demonstrated signifi-
cantly increased collagen in the intima and the adventi-
tia. The media of the pulmonary grafts had a collagen
density similar to those of the native tissues. There
were no significant differences among the grafts when
analyzed by donor type (syngeneic vs allogeneic), graft
treatment (fresh vs cryopreserved), or duration of
implantation.
The percentage of each graft that was media is shown
in Table II. When analyzed by histocompatibility, graft
treatment, or duration of implantation, there were no
significant differences between any 2 groups. However,
analysis by the combination of histocompatibility and
graft treatment demonstrated a significant difference by
analysis of variance. Application of the Bonferroni
inequality revealed a significantly greater proportion of
collagen in the cryopreserved allogeneic group than in
the fresh syngeneic group.
Immunohistochemistry. Representative hematoxylin
and eosin and immunohistochemical stains for procolla-
gen are shown in Figs 1-8. Procollagen was observed in
substantial quantities in the medial region of most trans-
planted pulmonary valves. This was true of all groups,
regardless of valve treatment and histocompatibility, and
at all implantation durations. The procollagen antibody
stained positively on cells between the elastic lamellae in
the medial walls of the grafts. Eighteen of 20 fresh syn-
geneic and 18 of 20 cryopreserved syngeneic grafts
exhibited the presence of procollagen, whereas 14 of 20
fresh allogeneic and 15 of 20 cryopreserved allogeneic
valves were positive. In general the distribution of pro-
collagen both in terms of concentration and location was
similar to that found in the native tissues. Procollagen
staining was observed in the media of only one native
pulmonary and no native aortic valve. Procollagen was
strongly present in the adventitial regions of all grafts and
was absent from the adventitia of all native valves.
Fig 1. Native pulmonary valve (hematoxylin and eosin stain).
L, Leaflet of valve; H, hinge region of valve; CM, cardiac
muscle.




The demonstration of procollagen in the media of
pulmonary valve grafts indicates that fibroblasts within
the graft are viable and are actively producing an
important structural protein. Collagen is the most abun-
dant matrix protein and is the one component of the
valve graft with the greatest influence on wall strength.
The increase in procollagen, the precursor molecule, in
the graft suggests that the graft has a capacity for
repairing damaged areas and adapting to the increased
Fig 2. Pulmonary valve graft (7-day cryopreserved allograft; hematoxylin and eosin stain). Increased inflammato-
ry cell response is evident. L, Leaflet of valve; H, hinge region of valve; CM, cardiac muscle.
Fig 3. Native pulmonary valve (serial section from tissue
block used to obtain Fig 1; immunohistochemical stain for
procollagen). Very little procollagen is present. L, Leaflet of
valve; H, hinge region of valve; CM, cardiac muscle.
Fig 4. Pulmonary valve graft (serial section from tissue block
used to obtain Fig 3; immunohistochemical stain for procol-
lagen). Arrows mark cells positive for procollagen. L, Leaflet
of valve; H, hinge region of valve; CM, cardiac muscle.
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hydrostatic pressure of the new environment. This may
explain the good immediate clinical results of the use
of allografts and the absence of frequent problems
related to rupture or aneurysm formation.
The increase in procollagen production observed in
pulmonary valve grafts echoes the results previously
obtained in this laboratory in a study of aortic valve
grafts.9 That investigation demonstrated that grafted
aortic valves exhibited larger concentrations of procol-
lagen than native aortic valves. As in the present study,
cryopreservation and immunologic differences did not
appear to substantially affect this procollagen produc-
tion. This investigation also confirms the previous
impression that procollagen deposition was removed
from sites of α-actin staining. This supports the
hypothesis that it is not smooth muscle cells that are the
most likely source of the procollagen. Rather, it is more
probable that fibroblasts are the source of the procolla-
gen synthesis. Finally, the present investigation also
used histologic morphometry that demonstrated, in a
quantitative manner, (1) the increase in intima in the
grafts, (2) the similarity of this property at all time
points of the study, (3) the similarity of this property
regardless of preservation methods or histocompatibil-
ity, and (4) the difference between aortic and pul-
monary roots.
The production of procollagen may represent a dou-
ble-edged sword, at least after longer periods of
implantation. Longer term results of procollagen syn-
thesis may be a loss of compliance, leading to rigidity,
and an obstructive effect. It is interesting that the gross
dilatation of the pulmonary grafts in this study was not
Fig 5. Native pulmonary artery from specimen shown in Fig
1 (hematoxylin and eosin stain). W, Wall of artery; m, media;
a, adventitia.
Fig 6. Pulmonary artery graft from specimen shown in Fig 2
(hematoxylin and eosin stain). W, Wall of artery; m, media, I,
intima; a, adventitia.
Fig 7. Native pulmonary artery (serial section from tissue
block used to obtain Fig 5; immunohistochemical stain for
procollagen). Very little procollagen is present. W, Wall of
artery; m, media; a, adventitia.
Fig 8. Pulmonary artery graft (serial section from tissue block
used to obtain Fig 6; immunohistochemical stain for procol-
lagen). Arrows mark cells positive for procollagen. W, Wall of
artery.
seen in the previous investigation of aortic grafts.9 A
likely approach to addressing this problem further will
require comparison of the present observations with
those in human tissues. Ideally, these observations
could use Western blot assays for quantitative evalua-
tion of procollagen production, as well as assays for
gene expression.
Although extensive experience has been gained
with experimental aortic valve grafts, experimental
pulmonary valve grafts have been much less thor-
oughly investigated. Most of the studies that exist
have been limited to observations of the mechanical
properties of the valve. Using a biomechanical
approach, Gorczynski and associates10 concluded that
fresh pulmonary valve leaflets exhibited a 300%
increase in normalized tensile strength when com-
pared with aortic valve leaflets in swine. David and
associates11 demonstrated similar stress to failure of
both aortic and pulmonary valve cusps. Gerosa and
colleagues12 also found that the aortic and pulmonary
valves displayed similar ultrastructural and biome-
chanical properties. This group found the pulmonary
valve leaflets to be more extensible than aortic
leaflets. These studies have been useful in supporting
the concept that the pulmonary valve is not inherently
weaker than the aortic valve and may be of equal or
superior durability when used as a graft.
The heterotopic implant model in the rat offers sever-
al advantages for investigating issues of valve graft
biology. It is relatively inexpensive and allows extreme-
ly precise degrees of immunologic incompatibility
between donor and recipient. Because the graft is
implanted in an intravascular location, it is exposed to
a normal arterial milieu with respect to pressure, pH,
and oxygen tension. In the aorta the graft is subjected
to mechanical stresses, such as shear stress and pul-
satility, like those experienced by the native aortic valve
or a pulmonary valve implanted in the aortic position.
These forces are probably not identical to those in the
orthotopic location because the competence of the
native aortic valve prevents this. This issue is important
because procollagen synthesis is at least partly regulat-
ed by mechanical forces.13 Therefore, it is important to
note that this study used a potentially competent valve
graft. Whether mobility of the leaflets and coaptation
actually occur is not known. Type I collagen, the type
examined in this study and the most abundant collagen
subtype in the heart, is less affected by mechanical
stimulation than is type III collagen, the second most
abundant type.14
Clinical studies that have attempted to distinguish
between aortic and pulmonary valve graft durability
have produced conflicting results. In the Ross proce-
dure the patient’s own pulmonary valve is placed into
the aortic position. This procedure has resulted in near-
ly 30 years of excellent results.15 The benefits of this
procedure appear to exceed those not only of mechani-
cal valve and bioprosthetic implants but also those of
allograft aortic valves.16
Pulmonary allografts used in the aortic position have
been used successfully, although with considerably less
frequency than aortic tissues.12,17-19 The aortic allograft
is more easily implanted in the aortic position because
its greater rigidity makes it easier to achieve proper
alignment of the graft with the native outflow tract. The
pulmonary allograft, however, can be used with com-
parable results in terms of immediate hemodynamics,19
intermediate-term freedom from complications,17,18
and patient survival.12
When used as a right ventricle–pulmonary artery
conduit, the pulmonary valve allograft has been sug-
gested by some studies to show no better1,20 or even
worse longevity than aortic valve grafts.3 Other centers
have found quite different results, with pulmonary allo-
grafts exhibiting less calcification5,21,22 and better long-
term graft survival than aortic valves.4,5
The extension of the rat heterotopic model to the pul-
monary valve graft has not been reported previously.
Even in this laboratory, with extensive experience with
the aortic graft implant, the pulmonary valve graft
required much practice and resulted in an overall mor-
tality of 33%. The establishment of this model will cer-
tainly be useful in addressing other important questions
regarding pulmonary valves and the potential differ-
ences compared with aortic valves.
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